Thermo Fisher Scientific Inc. (NYSE:TMO) VP Peter M. Wilver sold 9,079 shares of Thermo Fisher Scientific stock in a transaction dated Wednesday, March 15th. The stock was sold at an average price of $160.73, for a total value of $1,459,267.67. Following the transaction, the vice president now owns 62,517 shares of the company’s stock, valued at approximately $10,048,357.41. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) opened at 156.74 on Tuesday. The firm has a market capitalization of $61.19 billion, a P/E ratio of 30.79 and a beta of 1.10. The stock has a 50 day moving average of $156.21 and a 200-day moving average of $150.16. Thermo Fisher Scientific Inc. has a 52-week low of $137.40 and a 52-week high of $161.66.

Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings results on Tuesday, January 31st. The company reported $2.41 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.38 by $0.03. Thermo Fisher Scientific had a return on equity of 15.41% and a net margin of 11.06%. The business earned $4.95 billion during the quarter, compared to the consensus estimate of $4.98 billion. During the same period in the previous year, the business earned $2.12 EPS. The business’s quarterly revenue was up 6.5% on a year-over-year basis. Equities analysts expect that Thermo Fisher Scientific Inc. will post $9.16 earnings per share for the current fiscal year.

Insider Buying and Selling by Quarter for Thermo Fisher Scientific (NYSE:TMO)

The company also recently declared a quarterly dividend, which will be paid on Monday, April 17th. Stockholders of record on Wednesday, March 15th will be issued a $0.15 dividend. The ex-dividend date of this dividend is Monday, March 13th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.38%. Thermo Fisher Scientific’s dividend payout ratio (DPR) is 11.79%.

Your IP Address:

Several large investors have recently modified their holdings of the stock. Parsec Financial Management Inc. increased its stake in shares of Thermo Fisher Scientific by 0.6% in the third quarter. Parsec Financial Management Inc. now owns 1,938 shares of the company’s stock worth $308,000 after buying an additional 12 shares during the period. Choate Investment Advisors increased its stake in shares of Thermo Fisher Scientific by 0.4% in the third quarter. Choate Investment Advisors now owns 3,358 shares of the company’s stock worth $534,000 after buying an additional 15 shares during the period. Quadrant Capital Group LLC increased its stake in shares of Thermo Fisher Scientific by 0.6% in the third quarter. Quadrant Capital Group LLC now owns 2,844 shares of the company’s stock worth $442,000 after buying an additional 18 shares during the period. Savant Capital LLC increased its stake in shares of Thermo Fisher Scientific by 1.2% in the third quarter. Savant Capital LLC now owns 1,718 shares of the company’s stock worth $273,000 after buying an additional 20 shares during the period. Finally, Dorsey & Whitney Trust CO LLC increased its stake in shares of Thermo Fisher Scientific by 0.7% in the third quarter. Dorsey & Whitney Trust CO LLC now owns 3,079 shares of the company’s stock worth $490,000 after buying an additional 21 shares during the period. Institutional investors and hedge funds own 87.80% of the company’s stock.

A number of brokerages have recently issued reports on TMO. Deutsche Bank AG restated a “buy” rating and set a $163.00 price objective on shares of Thermo Fisher Scientific in a report on Wednesday, January 18th. Zacks Investment Research cut Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a report on Wednesday, December 14th. Goldman Sachs Group Inc restated a “conviction-buy” rating and set a $168.00 price objective (down previously from $170.00) on shares of Thermo Fisher Scientific in a report on Monday, December 12th. Jefferies Group LLC reduced their price objective on Thermo Fisher Scientific from $163.00 to $160.00 and set a “hold” rating for the company in a report on Monday, January 23rd. Finally, Evercore ISI boosted their price objective on Thermo Fisher Scientific from $160.00 to $162.00 and gave the stock a “buy” rating in a report on Tuesday, January 31st. Three investment analysts have rated the stock with a hold rating, nine have issued a buy rating and one has given a strong buy rating to the stock. The stock has an average rating of “Buy” and a consensus target price of $172.45.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

5 Day Chart for NYSE:TMO

Receive News & Stock Ratings for Thermo Fisher Scientific Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc. and related stocks with our FREE daily email newsletter.